Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I J Pachter

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Science (New York, N.Y.)|January 19, 1973
Drug abuseI J Pachter
Advances in Biochemical Psychopharmacology|January 1, 1973
Synthetic 14-hydroxymorphinan narcotic antagonistsI J Pachter
Drug and Alcohol Dependence|February 1, 1985
ButorphanolI J Pachter, R P Evens
Toxicologic Pathology|January 1, 1985
Review and evaluation of the NCI/NTP carcinogenesis bioassaysG H Hottendorf, I J Pachter
Proceedings. National Conference on Methadone Treatment|January 1, 1973
Methadone and naloxone in combination (Naldone) for the treatment of heroin addictsF S Caruso, M Gordon, I J Pachter
The Journal of Organic Chemistry|September 1, 1970
Cycloalkapyrrolones via decarboxylative ring closure of pyrrole-3-alkanoic acids and derivativesJ G Berger, S R Teller, I J Pachter
Antibiotics & Chemotherapy (Northfield, Ill.)|February 19, 2014
Tuberculostatic properties of some diphenylaminesM C KLOETZEL, I J PACHTER, C R SMITH, et al.
Journal of Medicinal Chemistry|February 11, 1976
Synthesis and evaluation of 1,omega-diaryl-l,omega-alkanediamines related to the fibrinolytic bis(tetrahydroisoquinolines) and bis(benzylamines)L J Fliedner, M J Myers, J M Schor, et al.
Journal of Medicinal Chemistry|July 1, 1971
Synthesis and structure-activity relationships of fibrinolytic bis(tetrahydroisoquinolines)L J Fliedner, J M Schor, M J Myers, et al.
Journal of Medicinal Chemistry|July 1, 1973
Synthesis and structure-activity relationships of fibrinolytic 1,omega-diphenyl-1,omega-alkanediaminesL J Fliedner, M J Myers, J M Schor, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Science (New York, N.Y.)|January 19, 1973
Drug abuseI J Pachter
Advances in Biochemical Psychopharmacology|January 1, 1973
Synthetic 14-hydroxymorphinan narcotic antagonistsI J Pachter
Drug and Alcohol Dependence|February 1, 1985
ButorphanolI J Pachter, R P Evens
Toxicologic Pathology|January 1, 1985
Review and evaluation of the NCI/NTP carcinogenesis bioassaysG H Hottendorf, I J Pachter
Proceedings. National Conference on Methadone Treatment|January 1, 1973
Methadone and naloxone in combination (Naldone) for the treatment of heroin addictsF S Caruso, M Gordon, I J Pachter
The Journal of Organic Chemistry|September 1, 1970
Cycloalkapyrrolones via decarboxylative ring closure of pyrrole-3-alkanoic acids and derivativesJ G Berger, S R Teller, I J Pachter
Antibiotics & Chemotherapy (Northfield, Ill.)|February 19, 2014
Tuberculostatic properties of some diphenylaminesM C KLOETZEL, I J PACHTER, C R SMITH, et al.
Journal of Medicinal Chemistry|February 11, 1976
Synthesis and evaluation of 1,omega-diaryl-l,omega-alkanediamines related to the fibrinolytic bis(tetrahydroisoquinolines) and bis(benzylamines)L J Fliedner, M J Myers, J M Schor, et al.
Journal of Medicinal Chemistry|July 1, 1971
Synthesis and structure-activity relationships of fibrinolytic bis(tetrahydroisoquinolines)L J Fliedner, J M Schor, M J Myers, et al.
Journal of Medicinal Chemistry|July 1, 1973
Synthesis and structure-activity relationships of fibrinolytic 1,omega-diphenyl-1,omega-alkanediaminesL J Fliedner, M J Myers, J M Schor, et al.
Pageof 2